top of page

Dr. Euler

教育DXシリーズ

AI SalesBooster

AIマーケティングサービス

DX2.0 AI ソリューション

ユーザー中心の AI 設計

Ingenta Design Service

inDesign Lab

AI ソリューション

テクノロジー

  DX推進  

ニュース

キャリア

私たちは急速に成長しており、素晴らしいものを一緒に創造するの優秀な人材が必要です。

ABOUT US

アイデアをデジタル商品につなげる

ABOUT COMPANY

An Innovative “Co-Creation” Beauty-Tech Joint Venture in Tokyo


Tokyo, Japan - April 5, 2019


Rohto Pharmaceutical Co. Ltd (Hamamatsucho, Tokyo) and Ingenta Inc. (Roppongi, Tokyo) strategically established Anomaly Inc. (Daikanyama, Tokyo), a pioneering beauty-tech joint venture aiming to penetrate the personalized haircare market. 


Anomaly Inc. provide personalized shampoos and conditioners by facilitating “co-creation” between hair stylists and consumers. Through interactive questionnaires and counseling services by hair stylists, each product is customized from ingredients to fragrance to fulfill individual’s  preference.


Operating on a B2B2C model, Anomaly Inc. partners with hair salons to offer personalized solutions directly to consumers, enhancing the salon experience and meeting the growing demand for customized beauty products.


"We are excited to launch Anomaly Inc. and usher in a new era of personalized haircare," said Dennis Hsueh, CEO of Ingenta Inc. "By leveraging Rohto's market capabilities and Ingenta's AI technology, we empower both stylists and consumers to co-create products tailored to their unique needs."


Anomaly Inc. represents a milestone in the beauty-tech industry, showcasing the power of collaboration and innovation to meet evolving consumer demands. With a commitment to personalized solutions and cutting-edge technology, Anomaly Inc. is set to redefine the future of haircare market.


 

About Anomaly Inc.

Establishment: 2019.04.03

Location: 8-7 Daikanyama-cho, Shibuya-ku, Tokyo

Capital: 96,500,000 JPY

Representative: Nobuhiro Hirasawa

 

About Rohto Pharmaceutical Co., Ltd.

ROHTO Pharmaceutical Co., Ltd is a multinational company with a history of over 120 years, renowned for its fast-moving consumer goods and OTC drugs. Headquartered in Osaka, Japan, with various domestic and overseas subsidiaries. Although we were initially known for OTC drugs, part of our DNA is to do the unexpected, and for the purpose of people and society’s well-being, we pursue businesses not limited to pharmaceutical operations. Our devotion to meet and exceed customer expectations is the core of Rohto’s business, which has been our main motivator and guidance throughout these years. Recently we announced our comprehensive Management Vision 2030, establishing the core areas we want to strengthen by 2030. With our spirit of "NEVER SAY NEVER" we strive to make every individual and society healthier.

 

About Ingenta Inc. 

Ingenta is a deep-tech Graph AI startup focusing on providing value-added AI core engines to our partners and customers. Rooted in extensive research, engineering experiences from Silicon


コメント


bottom of page